Pierre Fabre Medicament
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- France
- Registered address
- 16 rue Jean ROSTAND, Gaillac, Occitanie 81600, France (FRA)
- Operations here
- api manufacture
- FDA identifiers
- FEI 3002807889 · DUNS 267116254
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2022-07-08
- VAIDrug Quality Assurance2018-07-13
- VAIDrug Quality Assurance2016-04-15
- NAIDrug Quality Assurance2013-03-14
Drugs this plant is listed as making
1 distinct drugs across 4 products name this site in their FDA label.
- milnacipran hydrochlorideGlenmark Pharmaceuticals Inc., USA
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.